Piera Maiolino Selected Research

Piera Maiolino Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 10/2010
9	Melanoma (Melanoma, Malignant) 01/2023 - 04/2011
4	Lung Neoplasms (Lung Cancer) 03/2024 - 10/2010
4	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 01/2012
4	Carcinoma (Carcinomatosis) 01/2016 - 10/2010
3	Inflammation (Inflammations) 03/2024 - 05/2015
3	Rectal Neoplasms (Rectal Cancer) 05/2022 - 02/2016
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 07/2017 - 01/2017
3	Kidney Neoplasms (Kidney Cancer) 01/2016 - 01/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 09/2015
2	Squamous Cell Carcinoma of Head and Neck 07/2022 - 11/2016
2	Breast Neoplasms (Breast Cancer) 05/2021 - 09/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2017 - 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2024
1	Pneumonia (Pneumonitis) 03/2024
1	Lung Diseases (Lung Disease) 03/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024
1	Bites and Stings (Sting) 05/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Disease Progression 11/2022
1	COVID-19 08/2022
1	Multiple Myeloma 08/2022
1	Hemorrhage 05/2022
1	Pain (Aches) 05/2022
1	Microsatellite Instability 01/2022
1	Drug-Related Side Effects and Adverse Reactions 05/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018
1	Abdominal Obesity 05/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2016
1	Testicular Germ Cell Tumor 12/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2016

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 05/2017 - 10/2010
4	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2014
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2016
3	PlatinumIBA 01/2024 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2014
3	NivolumabIBA 11/2022 - 10/2019
3	VaccinesIBA 08/2022 - 02/2016
3	Bevacizumab (Avastin)FDA Link 01/2020 - 02/2016
2	LigandsIBA 01/2024 - 06/2011
2	InterferonsIBA 05/2023 - 04/2011
2	AntibodiesIBA 05/2022 - 01/2012
2	Fluorouracil (Carac)FDA LinkGeneric 07/2020 - 11/2016
2	Peptides (Polypeptides)IBA 07/2020 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2020 - 11/2014
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 11/2016
2	Cancer VaccinesIBA 01/2018 - 10/2015
2	Hormones (Hormone)IBA 05/2017 - 09/2015
2	Endocrine DisruptorsIBA 05/2017 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 11/2016
2	pazopanib FDA Link 01/2016 - 01/2016
2	Angiogenesis InhibitorsIBA 01/2016 - 01/2016
2	Capecitabine (Xeloda)FDA Link 01/2016 - 11/2014
2	Monoclonal AntibodiesIBA 05/2015 - 06/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 06/2011
2	adenylyl(3'-5')cytidine-3'-phosphateIBA 01/2014 - 09/2012
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2014 - 12/2013
2	Adenosine (Adenocard)FDA LinkGeneric 01/2014 - 09/2012
2	Interleukin-10 (Interleukin 10)IBA 12/2013 - 05/2011
2	OligodeoxyribonucleotidesIBA 05/2011 - 10/2010
1	SmokeIBA 03/2024
1	InflammasomesIBA 03/2024
1	Pemetrexed (MTA)FDA Link 01/2024
1	pembrolizumabIBA 01/2024
1	SphingosineIBA 05/2023
1	Phosphotransferases (Kinase)IBA 05/2023
1	Enzyme Precursors (Zymogens)IBA 05/2023
1	Messenger RNA (mRNA)IBA 05/2023
1	CeramidasesIBA 05/2023
1	Interleukin-6 (Interleukin 6)IBA 05/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	sotrovimabIBA 08/2022
1	Melphalan (Alkeran)FDA LinkGeneric 08/2022
1	Antineoplastic Agents (Antineoplastics)IBA 05/2022
1	B7-H1 AntigenIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2022
1	Trastuzumab (Herceptin)FDA Link 05/2021
1	Biosimilar PharmaceuticalsIBA 05/2021
1	Chemokine ReceptorsIBA 07/2020
1	Granzymes (Granzyme)IBA 10/2019
1	Protein Subunit VaccinesIBA 01/2018
1	1,10- phenanthroline- platinum(II)- ethylenediamine (PEPT)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 07/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2017
1	Biological FactorsIBA 05/2017
1	AdipokinesIBA 05/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2016
1	EnzymesIBA 12/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2016
1	Cetuximab (Erbitux)FDA Link 11/2016

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2024 - 10/2010
8	Therapeutics 07/2022 - 05/2011
3	Immunotherapy 01/2023 - 01/2022
2	Neoadjuvant Therapy 05/2022 - 06/2021
2	Radiotherapy 05/2022 - 02/2016
1	Stem Cell Transplantation 08/2022
1	Transplantation 08/2022